An overview of anti-Chikungunya antibody response in natural infection and vaccine-mediated immunity, including anti-CHIKV vaccine candidates and monoclonal antibodies targeting diverse epitopes on the viral envelope
Authors:
- Pankaj ChandleyPCPankaj Chandley
- Asha LukoseALAsha Lukose
- Rajesh KumarRKRajesh Kumar
- Soma RohatgiSRSoma Rohatgi
Open Access
- 8 November 2023
- journal article
- review article
- Published by Elsevier in The Microbe
- Vol. 1
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation (1354)
This publication has 170 references indexed in Scilit:
- Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralizationeLife, 2013
- Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical ProtectionThe Journal of Infectious Diseases, 2012
- Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinEMBO Molecular Medicine, 2012
- Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signalingVaccine, 2011
- A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisVaccine, 2011
- Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallographyNature, 2010
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionNature Medicine, 2010
- Prophylaxis and Therapy for Chikungunya Virus InfectionThe Journal of Infectious Diseases, 2009
- Chimeric alphavirus vaccine candidates for chikungunyaVaccine, 2008
- Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virusVaccine, 2008